| | |
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.058.833 |
| Chemical and physical data | |
| Formula | C8H6N2S3 |
| Molar mass | 226.33 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Oltipraz is an organosulfur compound belonging to the dithiolethione class. [1] [2] It acts as a schistosomicide and has been shown in rodent models to inhibit the formation of cancers in the bladder, blood, colon, kidney, liver, lung, pancreas, stomach, and trachea, skin, and mammary tissue. [3] [4] Clinical trials of oltipraz have failed to demonstrate efficacy and have shown significant side effects, including neurotoxicity and gastrointestinal toxicity. [3] Oltipraz has also been shown to generate superoxide radicals, which can be toxic. [5]